Read + Share
Amedeo Smart
Independent Medical Education
Whittington MD, Campbell JD, Rind D, Fluetsch N, et al. Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease. Neurology 2022 Jan 12. pii: WNL.0000000000013314.PMID: 35022306
Email
LinkedIn
Facebook
Twitter
Privacy Policy